SNTI
Senti Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.17
−2.75%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 363.79x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.58x
- Price / sales
- 97.96x
- Price / cash flow
- -0.14x
Enterprise value
- Enterprise value
- $19.2M
- EV / sales
- 348.20x
- EV / EBITDA
- -0.41x
- EV / EBIT
- -0.34x
- Market cap
- $5.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026